for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Emergent Biosolutions And Valneva Initiate Clinical Study To Evaluate Vaccine Against Zika Virus

Feb 26 (Reuters) - Emergent Biosolutions Inc:

* EMERGENT BIOSOLUTIONS AND VALNEVA INITIATE PHASE 1 CLINICAL STUDY TO EVALUATE VACCINE CANDIDATE AGAINST ZIKA VIRUS

* EMERGENT BIOSOLUTIONS INC - INITIAL DATA FROM PHASE 1 CLINICAL TRIAL OF VLA1601 ARE EXPECTED TO BE AVAILABLE IN LATE 2018 OR EARLY 2019 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up